Crystal structures of small GTP binding protein complexes with their effectors and regulators reveal that one particularly flat side of the G domain that contains helix α4 and the C-terminal helix α5 is practically devoid of contacts. Although this observation seems trivial as the main binding targets are the switch I and II regions opposite of this side, the fact that all interacting proteins, even the largest ones, seem to avoid occupying this area (except for Ran, that does not localize to membranes) is very striking. An orientation with this ‘flat’ side parallel to the membrane was proposed before and would allow simultaneous interaction of the lipidated C-terminus and positive charges in the α4 helix with the membrane while being bound to effector or regulator molecules. Furthermore, this ‘flat’ side might be involved in regulatory mechanisms: a Ras dimer that is found in different crystal forms interacts exactly at this side. Additional interface analysis of GTPase complexes nicely confirms the effect of different flexibilities of the GTP and GDP forms. Besides Ran proteins, guanine nucleotide exchange factors (GEFs) bury the largest surface areas to provide the binding energy to open up the switch regions for nucleotide exchange.
Most small GTP binding proteins except Ran are post-translationally modified with prenyl groups at either an N-terminal glycine (Arf family, myristoylation) or at the C-terminal CAAX box (Ras, Rho, Rab families, farnesylation or geranylgeranylation). Some G proteins are additionally modified by palmitoyl groups at cysteines preceding the CAAX box (e.g. H-Ras, N-Ras, K-Ras4A, Rap2A-B), whereas in others the palmitoylation site is replaced by a polybasic stretch (e.g. K-Ras4B, Rap1) (Colicelli, 2004; Tsai et al., 2015). As the prenyl groups are irreversibly attached, the membrane affinity conferred by those groups can be regulated only by helper proteins that bind to and shield the prenyl group from solvent, like the GDI-type proteins. In contrast, the palmitoyl groups are reversibly attached by DHHC proteins at the Golgi apparatus and can be removed by thioesterases. Candidate human thioesterases are APT1 and APT2 (Görmer et al., 2012). The closely related human protein LYPLAL1 has been shown to be unable to cleave palmitoyl chains (Bürger et al., 2012). The involvement of APTs in depalmitoylation is unclear, e.g. the orthologous protein to APT1/APT2 in toxoplasma can be knocked out without major consequences (Kemp et al., 2013), and APT1/2 inhibition/knockdown did not show a significant effect on N-Ras localization in NRAS mutant melanoma cells (Vujic et al., 2016), but inhibition of APTs (Rusch et al., 2011; Zimmermann et al., 2013) indeed altered Ras localization (Dekker et al., 2010). Efforts to exploit the palmitoylation machinery for therapeutic purposes are ongoing (Cox et al., 2015). Recently, other candidates for palmitoyl cleavage have been proposed, the ABDH17 family proteins (Lin and Conibear, 2015), and more might be found since the serine hydrolase family has many uncharacterized members.
From a structural viewpoint, the G domain (GTP binding domain) of the family of small GTP binding proteins is a versatile module that has evolved from an ancestral fold, the P-loop containing nucleoside triphosphate binding domain (Leipe et al., 2002; Ma et al., 2008). This fold is characterized by the presence of more or less flexible molecular ‘switch’ regions. According to the ‘loaded spring’ hypothesis (Vetter and Wittinghofer, 2001) the two switch regions are restrained in their dynamics by the γ-phosphate of a GTP molecule, so that the entropic penalty for binding of effector molecules and GTPase activating proteins (GAPs) especially to the switch I region is decreased. Consequentially, GDP binding increases the flexibility of the switches and attracts different interaction partners, the nucleotide exchange factors (GEFs) and the guanine nucleotide dissociation inhibitors (GDIs), using different additional contact regions.
The functionality of the G domain has expanded during evolution by introduction of various insertions (Wittinghofer and Vetter, 2011). The Rho/Rac/Cdc42 family has a small insertion of approx. 13 residues forming a short α-helix between helix α4 and β-strand β4 that does not change the conformation upon nucleotide hydrolysis and is usually not directly involved in effector binding. Arf/Arl/Sar proteins undergo a large conformational change of the G domain core where a register change of two β-strands causes the N-terminus, usually an amphiphilic, myristoylated helix, to detach from the protein core (therefore called ‘N-terminal switch’) so that it can interact with membranes or effectors (Pasqualato et al., 2002; Gillingham and Munro, 2007). Ran GTPases have an additional C-terminal helix that is destabilized if GTP is bound (called ‘C-terminal switch’; Vetter et al., 1999b).
Summaries of the structural features of G domain containing proteins can be found in the following references: Vetter and Wittinghofer (1999), Paduch et al. (2001), Cherfils and Zeghouf (2011), Wittinghofer and Vetter (2011) and Vetter (2014). In the following, structural characteristics of complexes of small GTP binding proteins are highlighted, with a focus on the implications for orientation at the membrane.
Post-translational modifications and other structural determinants of membrane orientation
In the available crystal structures of small GTP binding proteins, the C-terminal hydrophobic modifications are rarely present as they render the proteins very poorly soluble. Thus, prenylated GTPases usually crystallize only in complex with GDI proteins that chaperone the hydrophobic group, like the RabGDI Ypt1 (1UKV; Rak et al., 2003), RhoGDIs [(1DOA; Hoffman et al., 2000), 1HH4 (Grizot et al., 2001), 4F38 (Tnimov et al., 2012), 5FR2; Kuhlmann et al., 2016)], PDE6δ (3T5G; Ismail et al., 2011) or REP (Rab escort protein, 1VG0; Rak et al., 2004). The lipid modification site is separated from the G domain by a hypervariable region (HVR, 167-189, Figure 1B) that is assumed to be flexible and is normally deleted for crystallization, so that there are only a few crystal structures of full-length GTPases. For Ras proteins, one structure is H-Ras-GDP 1-189 (4Q21; Milburn et al., 1990); the second one is K-Ras4B 1-189 (GDP, 4DSU, GSP, 4DSO; Maurer et al., 2012). In the H-Ras structure (4Q21), the C-terminal helix (α5) is visible up to Leu168, so this structure does not contribute much additional information compared to the truncated structures (usually comprising residues 1-166). In the K-Ras structures (4DSU, 4DSO), the C-terminal helix continues up to residue Asp173, which is the last residue with unambiguous electron density (Maurer et al., 2012). The remaining residues 174–180 that contain the polybasic region, mostly lysines, have only weak electron density, indicating their intrinsic flexibility, and are assumed to facilitate the interaction with the negatively charged lipid head groups of membranes (Figure 1B) (Maurer et al., 2012). The farnesylated cysteine of the CAAX box follows shortly after the positively charged region at residue 185 (CVIM). Many Rho family GTPases have a similar HVR compared to Ras (Vidal, 2010) in terms of length and (positive) charges. Rab proteins tend to have a C-terminal helix that is longer than in Ras protein structures [e.g. up to 13 residues in Rab11A (3BFK, unpublished), Rab11B (2F9M; Scapin et al., 2006) and Rab7 (1VG8; Rak et al., 2004)], and Rab proteins also have a longer linker between the helix end and the lipid modification site. For example, Rab11B (2F9M) has 25 residues between the last amino acid in the structure and the CC motif di-geranylation site, Rab7 (1VG8) has 18 residues separating the helix end from the analogous CXC motif. This region is most likely flexible and thus is often deleted or not visible in the crystal structures.
In conclusion, the crystal structures indicate that the lipid modification site at the very C-terminus of small GTP binding proteins is attached via a linker region to the core domain that can be either relatively short, stiff and highly charged (as in K-Ras) or relatively long, poorly conserved and probably flexible (as in the Rab proteins), so that the constraints on the specific membrane orientation of the G domain core will necessarily be different.
In H-Ras, some basic residues in the core of the G domain have been proposed to contribute to membrane association besides the lipid modification, namely R128, R135, and R161 (Abankwa et al., 2008). The positive charges at these positions are conserved in K-Ras and N-Ras: Position 161 is always arginine, K-Ras has a lysine at 128, and N-Ras has lysines both at positions 128 and 135. Indeed, if the C-terminal helix (α5) is oriented parallel to the membrane, the positive charges at those three sites are optimally positioned for interaction with the membrane (Figure 1). This orientation has been proposed as the favored one for the GTP form of H-Ras and N-Ras (Gorfe et al., 2007; Prakash and Gorfe, 2016), and this hypothesis was supported with more evidence later (Kapoor et al., 2012; Šolman et al., 2015). Recently, it has also been described as one of the dominant orientations in K-Ras (Prakash et al., 2016), and possibly in other small GTPases, e.g. RheB, as highlighted in a recent review (Prakash and Gorfe, 2016). It is also notable that this side of the G domain appears relatively flat, with the C-terminal helix defining one axis of this ‘plane’, and a line between the β-hairpin at residue 47 and residue 135 defining the other axis (Figure 1).
In Ras-related GTPases, the three positive charges are not always conserved: Rab proteins have R/K at the position corresponding to Ras R161, but positions 128 and 135 are not conserved (at 128, e.g. R,K,E,Q,D, at position 135, e.g. R,K,D,Y). In the Rho family, positions corresponding to R161 and R135 in Ras are conserved as R/K, but position 128 has no positive charge, but is often E,Q or D. In Arf proteins, position 135 is mostly histidine, but the other two positions often have negative charges. A summary of the charge distributions in helices α4 and α5 can be found in a recent review (Prakash and Gorfe, 2016). In addition, Arf proteins, the major traffic regulators in the cell besides Ran and Rab proteins, have their lipid modification at the N-terminus instead of the C-terminus, and therefore will be described in some more detail in the following.
Similar to Ran, the Arf-family GTPases feature an additional switch mechanism that drastically remodels a part of the G domain. Where Ran has the C-terminal helix attached to the G domain core in the GDP form and detached in the GTP form, Arf proteins exhibit a shift of one β-strand in the G domain core upon replacement of GDP with GTP that pushes out the myristoylated N-terminus, the ‘interswitch toggle’ (Pasqualato et al., 2002). The N-terminus often forms a short helix that, in addition to myristoylation, is usually amphipathic (Huang et al., 2001; Vetter and Wittinghofer, 2001; Gillingham and Munro, 2007; Donaldson and Jackson, 2011; Lin and Conibear, 2015). The linker following this helix, as well as the C-terminus, often carries positive charges to facilitate membrane attachment (Liu et al., 2010). In some cases, the N-terminal helix can provide sufficient membrane affinity even without myristoylation, e.g. in Sar1 and Arl6, where the lack of the lipid group is compensated by additional hydrophobic residues at the N-terminus (Huang et al., 2001; Gillingham and Munro, 2007). The two attachment sites, i.e. the hydrophobic/amphiphilic N-terminus and the charged C-terminus, can restrain the orientation of Arf proteins at the membrane. Interestingly, NMR studies have led to a model where the C-terminal helix of Arf (that contributes to the plane of the ‘flat’ side) again lies almost parallel to the membrane (Liu et al., 2010). It is thus tempting to assume that the N-terminus of Arf proteins takes over the role of the positively charged positions 128 and 135 in Ras proteins as membrane anchor point.
In summary, the available structural information for small GTP binding proteins contributes to explain the experimental evidence for the different modes of membrane binding. Besides the properties of the G domain itself, analysis of the overall shape of structures of effector complexes that often form in direct vicinity of the membrane might give some additional information about the membrane orientation of those complexes, as described in the following.
Effector complexes of small GTP binding proteins – implications for membrane orientation and comparison of interaction surfaces
Effector proteins of small GTP binding proteins bind – per definition – to the GTP-bound form of the G domain. Superimposition of the available complex structures of membrane-interacting GTPases with their effectors reveal the interesting picture that one side of the G domain is left completely free (Figure 2A). This could be attributed to the fact that the switch regions that indicate the presence or absence of the γ-phosphate are at the opposite side of the G domain, and the effector molecules naturally do cluster around the switch regions of the G domain (Figure 2B). On the other hand, is still striking that even the largest effector molecules would not clash with the putative membrane position, and that – probably not coincidentally – this ‘flat’ side corresponds exactly to the orientation predicted for the H-Ras GTP form (Figure 1). This orientation would allow simultaneous interactions of all arginines and the C-terminal lipid modification with the membrane while still bound to the effector molecule. It also corresponds to one of the major two orientations observed for the oncogenic mutant G12D of K-Ras, called ‘OS1’ in Prakash et al. (2016). There, it was already noted that the RafRBD effector domain would clash with the membrane in a second predicted orientation (denoted as ‘OS2’), in contrast to ‘OS1’. A third position features helices α3 and α4 parallel to the membrane, as predicted e.g. for K-Ras and Arf (Prakash and Gorfe, 2016). In this orientation (Figure 2C), the main clashes with the membrane would be with the formin- and the LidA-complexes (the latter not shown in Figure 2C for clarity). Figure 2D depicts the same orientation, but with the formin complexes omitted, now revealing potential membrane clashes of the Arf6-effector JIP4 (2W83; Isabet et al., 2009), and the Rab6-effector R6IP1 (3CWZ; Recacha et al., 2009), that is recruited to Golgi membranes by active Rab6 (Recacha et al., 2009). The coiled coil helix of JIP4 was proposed to be oriented parallel to the membrane (Isabet et al., 2009), which would also argue against membrane interaction of the α3/α4 side in those complexes. In addition, it is evident that the α4/α5/β-hairpin interface (the ‘flat’ side) would bury a slightly larger interface with the membrane compared to the α3/α4 side, namely 2460Å compared to 1847Å, i.e. an about 25% larger surface area of the G domain, indicating a potentially more stable membrane association of the former.
Looking at the distribution of positive charges in those complexes, the arginine/lysine clusters of the three positions corresponding to H-Ras R128, R135 and R161 are clearly visible as an acute triangle (Figure 3B). As discussed by Prakash and Gorfe (2016), orientational restraints might also be relevant for G-domains of other small GTP-binding protein families, and this idea is corroborated by several crystal structures as highlighted in the following. A distinctive basic cluster is notable in a short helix close to the putative membrane that belongs to the F2 lobe of the FERM domain of KRIT-1 in complex with Rap1B [(4DXA; Li et al., 2012), 4HDO/4HDQ (Gingras et al., 2013)] with the motif ‘KKHK’ (Figure 3A). This motif was postulated to be a NLS (Zawistowski et al., 2005), but in C2 domains, similar motifs are thought to confer affinity to membranes (Thomas et al., 1999). Mutation of a lysine (K570) in the KKHK motif reduced the affinity to Rap1B as it is involved in a salt bridge to E45 of Rab1B (Gingras et al., 2013), but that would not exclude a possible additional contribution to membrane interaction. The FERM domain has other interaction sites for the membrane as well that would not be compatible with the orientation in Figure 3, so it would be interesting to obtain experimental support for this speculation, and, furthermore, to check if similar motifs in other effector molecules might also facilitate membrane attachment. In case of Rho proteins, the function of the insert helix (Figure 3B) is still unclear. It usually does not interact directly with effectors, with the exception of some minor contacts at the tip of the helix in some complexes (e.g. in Cdc42-FMNL2, 4YC7/4YDH; Kühn et al., 2015), but the insert has been found to be essential, e.g. for activation of the Rho kinase (Zong et al., 2001). Interestingly, the insert helix lies almost parallel and very close to the membrane in the orientations shown in Figures 2 and 3, and also features some positive charges (Figure 3B). Indeed, it was speculated that the insert could also be important for fine-tuning the orientation of Rho proteins at the membrane (Vidal, 2010). Fittingly, effector complexes of Ran – that does not interact with membranes during cargo transport through the nuclear pore – show the ‘flat’ side of the G domain completely blocked and buried by the huge helical solenoids of the transport proteins (karyopherins) that cover almost the entire surface of the Ran protein.
Analysis of the contact areas between the G domain and the effectors also reveals some characteristic differences between membrane-bound GTPases and Ran proteins: Effector complexes of the former typically show relatively small buried surface areas, corresponding to the transient nature and moderate affinities of those interactions (on average 785 Å2 for 74 structures containing 139 sub-complexes (i.e. heterodimeric complexes), analyzed with PISA, (Collaborative Computational Project, Number 4, 1994). Values range from 422 Å2 (Rab6-golgin-GCC185 complex; Burguete et al., 2008) to 1860 Å2 (Rab27-SLAC2-A/melanophilin complex; Kukimoto-Niino et al., 2008). In contrast, the karyopherins are snail-like α-helical solenoids that wrap around the Ran G domain and bury up to 2503 Å2 in the interface (Crm1-RanQ69L complex 3NC1; Güttler et al., 2010), leading to picomolar affinities. On average, 1997 Å2 are occluded in the interfaces of Ran-effector-complexes (45 structures containing 65 sub-complexes). In these complexes, nucleotide hydrolysis is almost completely abolished, which is essential for Ran function, as otherwise the karyopherin complexes would dissociate in the wrong cellular compartment or during transit through the nuclear pore. Other effectors can have different effects on the GTP hydrolysis rate, they can either leave the rate unchanged or even accelerate it slightly (Vetter, 2014). In karyopherins, hydrolysis suppression is achieved by remodeling switch II so that the catalytic glutamine is in a hydrolysis incompetent position (Vetter et al., 1999a). Later it has been shown that the conserved Tyr39 in switch I of Ran proteins also contributes to the slow hydrolysis in Ran effector complexes by interfering with the optimal position of the catalytic water molecule (Rudack et al., 2015). In all Ran GTP forms, the (additional) C-terminal helix (α6) is detached from the core G domain, and in case of the karyopherin complexes, it is usually disordered and not visible in the structures. In contrast, another type of Ran effectors, the Ran binding domains (RanBD), are designed to capture the (flexible) C-terminus of Ran-GTP and wrap it around themselves (Vetter et al., 1999b). Although the Ran binding domains are quite small with a molecular weight of approx. 16 kDa, the ‘molecular embrace’ of Ran with a RanBD buries almost as much surface as the large karyopherin complexes (2350 Å2), along with having a very high affinity in the low nanomolar range. Thus, the type of effector complexes formed by Ran is fundamentally different from the membrane-attached GTPases as Ran effectors cover much larger surface areas of the G domain.
GAP (GTPase activating protein) and GEF (guanine nucleotide exchange factor) complexes
Similar to the effectors (Figures 2 and 3), the superimposition of the GAP complexes leaves the ‘flat’ side of the G domain free (Figure 4A). Since many GAPs are membrane-bound or recruited to the membrane to stimulate GTP hydrolysis and thus create the GDP-bound form of the G domain, it would again seem logical to allow for simultaneous interaction of the G domain with the GAP and the membrane. The only exception is again the Ran-RapGAP-RanBD complex (Figure 4, gray and pink) where the linker of the C-terminal helix of Ran and the N-terminus of RanBD covers the ‘flat’ side of the G domain, but this complex is most likely not attached to membranes anyway.
Analysis of the interfaces in GAP complexes reveals that ArfGAPs tend to have the smallest solvent excluded areas of all GAPs, e.g. the ArfGAP/ankyrin domain of ASAP3 (3LVR/3LVQ; Ismail et al., 2010) buries only 562/715 Å2, corresponding to a relatively low affinity, and thus had to be crystallized as a fusion protein (Ismail et al., 2010). As in most other GAP complexes, additional domains (like e.g. a PH domain that would facilitate membrane attachment) are missing in the ArfGAP construct that could compensate for the low affinity by e.g. increasing the local concentration of the GAP at the membrane. RhoGAPs bury larger interfaces in their complexes, ranging from 715 to 1184 Å2 (15 sub-complexes in 11 PDB structures), similar to RabGAPs, which have related sequences and structures amongst each other (TBC domains), and bury 1036–1233 Å2 (6 sub-complexes in the two structures 4HLQ and 2G77). Several RabGAPs have regions with positive charges following their catalytic domains that are thought to be involved in membrane localization (Kuhlmann et al., 2016).
Bacterial GAP mimics like the Legionella protein LepB are in the same range of interface areas [1098-1305Å2, 8 sub-complexes of 3 structures: 4JVS (Yu et al., 2013), 4I1O (Gazdag et al., 2013), 4IRU (Mishra et al., 2013)] although they are mechanistically very different: they stabilize the catalytic glutamine of the switch II region in analogy to RanGAP, in contrast to the TBC GAPs that provide this glutamine in trans. Another bacterial GAP is the MglB protein that regulates cell polarity in the bacterium Myxococcus xanthus (Miertzschke et al., 2011) together with the GTPase MglA. MglA forms a complex with a MglB homodimer (3T12; Miertzschke et al., 2011) and buries 1188 Å2, which is in the lower range. As mentioned above, the RanGAP-Ran complex does not form at the membrane, but probably at the filaments of the mammalian nuclear pore where the RanBP2 protein is located. RanGAP has been crystallized in form of a ternary complex with Ran and a Ran binding domain of RanBP2 (1K5G/1K5D; Seewald et al., 2002). The Ran binding domains help to sequester the Ran proteins that exit the pore in form of karyopherin-complexes (Sarić et al., 2007) and subsequently facilitate GTP hydrolysis (Seewald et al., 2003). In this complex, the Ran-RanBD1 buries 2730Å2 whereas the interface between Ran and RanGAP buries 1300 Å2, which is average for a GAP. The largest GAP-G domain interfaces are found in RasGAPs (1420 Å2, 1WQ1; Scheffzek et al., 1997) and RapGAPs (Rap1·RapGAP 1094 Å2 3BRW; Daumke et al., 2004; Scrima et al., 2008), with the record holder Rap1·Plexin C1 with 1610–1734 Å2 (4M8N; Wang et al., 2013). Probably due to the fact that they do not have to unfold parts of the G domain, the GAP proteins tend to be slightly less ‘engulfing’ than the GEFs described in the following. (GAPs bury on average 1205 Å2 in 36 structures with 77 sub-complexes, GEFs 1407 Å2 in 69 structures with 115 sub-complexes).
As expected from proteins that have to open the nucleotide binding site for nucleotide exchange by binding to the often completely unfolded switch regions, GEF complexes tend to bury the largest interface areas observed in small GTPase complexes, up to 2259 Å2 in the Cdc42-DOCK9 complex (2WM9; Yang et al., 2009). In contrast to all complexes described so far, superimposition of the GEF complexes (Figure 4B) reveals that some GEF domains would clash with the membrane in the depicted orientation of the G domain, but not by a large amount. Interestingly, they all belong to GEFs of the DOCK family, in contrast to the DH-PH-domain containing GEF family. The largest clash is seen for the helical domain of the Cdc42-GEF DOCK9 (2WM9/2WMN/2WMO; Yang et al., 2009), followed by the Rac1-DOCK9 complexes [(2YIN; Kulkarni et al., 2011), 3B13 (Hanawa-Suetsugu et al., 2012)], where DOCK9 is slightly rotated compared to the Cdc42 complex, and lastly the Cdc42 complex with the DHR-2 domain of DOCK8 (3VHL; Harada et al., 2012). In all structures, the DHR-1 domain is missing that directly interacts with the membrane via its C2 domain fold, but the complete DOCK1-Rac1 has been modeled (Premkumar et al., 2010). In the model, the C-terminal helix of Rac is again almost parallel to the membrane, and the β-hairpin (Figure 1A, position 47) is close to the membrane. Thus, only a slight rotation is needed from the orientation in Figure 4 to avoid the clash with the membrane. In summary, also the GAP and GEF complexes would argue for the possibility of a preferred membrane interacting side of the G domain.
Interactions with the GDP state
As expected from the more dynamic state of the switch I and switch II regions in the GDP form, where they are not restrained by the γ-phosphate of GTP, there are relatively few proteins that bind to the GDP form of GTPases: in nuclear transport, NTF2 facilitates trafficking of the ‘empty’ RanGDP through the FG-repeat meshwork of the nuclear pore (Zahn et al., 2016), and the zinc finger domains of Nup153 at the inner ‘basket’ of the nuclear pore might form a storage site for RanGDP waiting for its GEF RCC1 to exchange the nucleotide (3CH5; Schrader et al., 2008). The buried areas are rather small, on average 765 Å2 for NTF2 (two structures with six sub-complexes), and 513 Å2 for the zinc fingers, respectively, (seven structures with 11 sub-complexes) indicating a weak interaction consistent with the transient nature of the sequestration at the nuclear basket for the zinc finger domains (Schrader et al., 2008). The interacting proteins are very different for membrane-localized G proteins: GDI proteins (GTP dissociation inhibitors) and the related REP protein bind to the Rho and Rab families, and the Arf effector Arfaptin binds to Rac1 in a GDI-like way both in the GTP and GDP form (Tarricone et al., 2001). GDIs come in three structural classes: RhoGDI, RabGDI and PDE6δ/UNC119 (Cherfils and Zeghouf, 2013). GDIs usually bind similarly to GDP and GTP forms of the G domain and therefore have to avoid contact to the switch I region (Figure 5A and B). Instead, they concentrate their interactions to the vicinity of the switch II region and to the C-terminal region close to their main binding target, the prenyl moiety at the C-terminus.
RhoGDIs have a loop with positive charges (Figure 5B) for membrane attachment, in addition to a negatively charged stretch at the N-terminus that is thought to bind to the C-terminal basic region of Rho/Cdc42/Rac proteins close to the lipid modification site that provides additional membrane affinity for the complex (Tnimov et al., 2012). This would allow orienting the complex again with the ‘flat’ side of the G-domain close to the membrane (Figure 5B). In contrast, the RabGDIs can not be positioned in a way that the mobile effector loop (residues 225–228; Ignatev et al., 2008) close to the prenyl binding site (Figure 5D, highlighted in red) and the ‘flat’ side of Rab can reach the membrane at the same time. But it would be feasible for the RabGDIs to bind to Rab if it were in the position depicted in Figure 5D since there would be no clashes with the membrane, and subsequently extract Rab by binding to the lipid anchor and the membrane as postulated (Ignatev et al., 2008).
Interestingly, some toxins and pathogens use a similar mechanism to GDIs for binding to the GDP forms of G proteins: SopB (4DID; Burkinshaw et al., 2012) and the C3-exoenzymes [2A9K/2A78; (Pautsch et al., 2005), 2BOV (Holbourn et al., 2005)] slow down nucleotide exchange by occupying similar surface regions as GDIs, which seems natural since they have the same task of binding to the GDP form while coping with the relatively high flexibility of the switch regions. SopB buries a slightly larger interface area than the GDIs, 1765 Å2 (4DID) compared to 1594 Å2 for RabGDI (1UKV; Rak et al., 2003). The Fic domains of adenylylating proteins found in pathogenic bacteria (e.g. IbpA, 3N3V; Xiao et al., 2010) are also attached to the more rigid parts of the G domain (Roy and Cherfils, 2015), but their α-helical domain extends to the switch I region to access the tyrosine that is adenylylated (Figure 5C).
Examples for the third class of solubilizing proteins that bind to the C-terminal prenyl groups are PDE6δ/UNC119. An interaction solely via the prenyl group, i.e. with only very few direct contacts between the G domain and PDE6δ, is structurally characterized in the RheB·GDP-PDE6δ complex (3T5G; Ismail et al., 2011). Accordingly, this interaction most likely imposes no steric restraints on the relative orientations of the two domains. Arl proteins, that are mostly not myristoylated themselves (Donaldson and Jackson, 2011), are involved in transport of hydrophobic prenylated cargo bound to e.g. the UNC119 domain (Ismail et al., 2012). In contrast to Arf proteins that attach to a membrane via their N-terminus that often forms an amphiphatic helix, Arl proteins do not detach the N-terminus in the GTP state, at least not completely. It was speculated that this renders the Arl3-UNC119-cargo complex soluble until recruited to ciliar membranes by the specific membrane-bound GAP RP2 (Ismail et al., 2012), where cargo is released by triggering GTP hydrolysis. A similar mechanism of rendering prenylated cargo soluble is used by the PDE6δ domains that interact with high-affinity cargo like INPP5E which is released by Arl3 in cilia, perhaps aided by the scaffold protein RPGR (retinitis pigmentosa GTPase regulator) that can directly interact with PDE6δ (Wätzlich et al., 2013). In contrast, cargo that binds PDE6δ with low affinity can be released by Arl2 everywhere in the cell (Fansa et al., 2016). Other domains, like the C2 domain of RPGRIP1, probably compete with PDE6δ (Remans et al., 2014) for RPGR binding. Arfaptins behave like a GDI towards Rac1, i.e. they bind Rac in both nucleotide states and sequester Rac until it is displaced by the GTP-bound forms of Arf1 and Arf6 (Tarricone et al., 2001), and thus might have a somewhat similar function to PDE6δ (Hanzal-Bayer et al., 2002).
The only other types of GDP-containing complex structures are either GEFs, or effectors (or mutants thereof) that have affinities that are sufficiently high to enable binding to the GDP forms of some GTPases as described in the following.
Interaction of effectors with the GDP state forced by high affinity
If the affinity to the effectors is sufficiently high, they can bind the G domain even in the GDP-bound form. Examples are the Ran-karyopherin complexes (Villa Braslavsky et al., 2000), e.g. RanA181C-Kap95P (3EA5; Forwood et al., 2008) with a huge buried surface of up to 2182 Å2 that provides sufficient binding energy to force the switch regions into the GTP conformation. Another interesting case are complexes of Ras with the Ras binding domain (RBD) of e.g. Raf kinase, where the RBD has been mutated (A85K) for higher affinity (Ras-RBDA85K/Rap1A E30DK31E, 3KUD/3KUC; Filchtinski et al., 2010). The increased affinity enabled crystallization of the H-Ras·GDP-RBD(A85K) complex that showed the switch I region forced into the GTP conformation by the RBD, but coinciding with high temperature factors of the switch I region and the attached RBD, consistent with the higher flexibility expected from switch I when the γ-phosphate is missing (Filchtinski et al., 2010). This illustrates the delicate balance between effector affinity and flexibility/dynamics of switch I. The dynamics of switch I can also be influenced by small molecules like cyclen (Rosnizeck et al., 2010), and some G domains have intrinsically increased dynamics, e.g. Rac1b, caused by a destabilizing insert (Fiegen et al., 2004), so that this protein has a drastically reduced affinity to the nucleotide and does not even require a GEF protein. The last two cases of GTPase-GDP complexes occur in Arl2, where the protein can be purified in the GTP-bound form if co-expressed with its effector PDE6δ, but where the GTP is partially hydrolyzed in one of the crystal forms so that it contains 3:1 GDP/GTP as confirmed by HPLC (Hanzal-Bayer et al., 2002), and in the complex of Rab1 with the coiled-coil domain of LidA (3SFV; Cheng et al., 2012), an effector mimic, that is able to bind both the GTP and GDP and renders Rab persistently active (Cheng et al., 2012).
Analyzing the self-interaction of G domains
Dimerization of Ras proteins at the membrane has been predicted by several groups now (e.g. Inouye et al., 2000; Güldenhaupt et al., 2012; Muratcioglu et al., 2015; Jang et al., 2016). Besides e.g. molecular dynamics simulations, crystal structures were also consulted to find putative dimerization interfaces, and a Ras dimer with an interface formed by helices α4, α5 and the β-hairpin (i.e. the ‘flat’side) was described in (Güldenhaupt et al., 2012) that occurs in four different space groups and in the majority of the available crystal structures (50 of 71 structures). It is important to note that these dimers are mostly formed by crystallographic neighbors in the crystals, i.e. there are G domain monomers in the asymmetric unit. An analysis of the buried interface areas in the available crystal structures of solitary GTPases with PISA (Collaborative Computational Project, Number 4, 1994) indeed reveals that the largest interface areas are buried in this α4/α5/β-hairpin dimer, and that the same dimer actually occurs not only in seven different crystal forms of H-Ras (2RGC; Buhrman et al., 2007), 2QUZ/4L9S (Denayer et al., 2008; Ostrem et al., 2013), 3LO5 (Nassar et al., 2010), 1QRA/2RGG (Scheidig et al., 1999), 1AGP (Franken et al., 1993), 1IAQ (Spoerner et al., 2001), 3KKM (Shima et al., 2010), but also in one crystal form of K-Ras (4EPR; Sun et al., 2012) and one form of RhoE (1GWN; Garavini et al., 2002). K-Ras 4EPR has the same crystal parameters as H-Ras 3KKM, with the one of the momomers very slightly rotated compared to H-Ras (Figure 6). RhoE (1GWN) shows a similar dimer, although rotated some more, in yet another crystal form. In Ran, the C-terminal helix and the linker blocks the ‘flat’ side in the GDP form, but side chains in the interface are so different that this dimer could not form anyway, not even in the GTP form.
Although the superimposed dimers are very similar (Figure 6), the buried surface areas vary quite a bit due to slight differences in loops and side chain orientations in the wild type and mutant crystals in the different space groups. The largest area is 918Å2 in 2RGC (H-Ras Q61V-GppNHp; Buhrman et al., 2007), the smallest 772/766 Å2 in 1QRA(H-RasGTP)/2RGG(H-RasQ61I-GppNHp). N-Ras has very few amino acid substitutions in this dimer interface compared to H-Ras and K-Ras, only His131, Lys135 and Tyr166 are different to both H- and K-Ras. Although it should therefore be theoretically possible for N-Ras to form the same dimer, a different packing with a very small interaction area (335Å2) is found in the only available crystal structure of N-Ras (3CON, unpublished). The very different packing might have been caused by the in situ partial proteolysis with chymotrypsin during crystallization that left the switch II region either completely disordered or even digested.
As described above, it would be interesting to know if full-length Ras proteins would be able to form the same dimers as the truncated forms that are used for the overwhelming majority of crystal structure determinations. The closest to full length structures in the PDB are K-Ras 4DSU and 4DSO (Maurer et al., 2012). Both GDP and GSP forms crystallize as monomers and in the same crystal form, with the C-terminal basic lysine stretch (residues 175–180, Figure 1) mostly disordered and loosely packing into a neighboring, symmetry-related molecule, burying only 427 Å2. No interface in the crystals resembles the α4/α5/β-hairpin dimer interface described above. One reason could be a potential clash of the (extended) C-terminal helix: superimposing 4DSU on top of the 1QRA dimer would cause Arg135 to clash with Glu168 of the second monomer. The C-terminal helix seems to be relatively rigid, the temperature factors are only slightly increased, and only the polylysine tail is probably very flexible, so this could be a possible explanation why the α4/α5/β-hairpin dimer is not seen in the crystals. On the other hand, the clash is not severe, and might be circumvented by minor side chain adjustments or domain rotations. Another reason for the absence of the α4/α5/β-hairpin dimer in full-length K-Ras could be that the charged lysine tail causes this specific packing as it might accidentally fit better into the neighboring molecule this way.
In summary, the crystallographic α4/α5/β-hairpin dimer that shows a direct face-to-face interaction of the H-Ras/K-Ras/RhoE G domains might be physiologically relevant, although it probably has a very low affinity and would need to be enhanced by other components, e.g. the lipid modification. Indeed, an intact CAAX box was shown to be necessary for dimerization of K-Ras (Nan et al., 2015). One could envision both a negative regulation of the interaction with membranes by the dimer blocking the ‘flat’ side of the G domain, or, on the other hand, a dimerization could tilt the G domains away from the membrane while staying anchored via the lipid modified C-terminus as proposed, e.g. for the Ras GDP form (Gorfe et al., 2007) or for K-Ras G12D in the GTP form (Prakash et al., 2016), and two effector molecules could then bind at the same time. A dimerization of effectors is thought to be required for activation of, e.g. Raf-1 kinase (Freeman et al., 2013), and Ras dimers were shown to form to activate MAPK (Nan et al., 2015), so a direct dimerization via the ‘flat’ face could be a possible mechanism. Other dimers have been postulated (Muratcioglu et al., 2015; Jang et al., 2016; Sayyed-Ahmad et al., 2016), but from the crystallographic point of view the interaction that buries the largest surface area is the most likely one. A dimer via the effector interacting β2-strand has just been regarded as most likely not physiologically relevant (Sayyed-Ahmad et al., 2016).
Conclusions and future directions
It is evident that the crystal structures of small GTP binding proteins and their complexes have contributed tremendously to elucidate the detailed interactions with their effectors and regulators. The defining feature of this protein family is a delicate balance between entropic repulsion by the switch regions that are more flexible in the GDP form as compared to the GTP form, and the enthalpic binding energies. Large interaction surfaces are needed to provide sufficient affinity especially for the GEF proteins that have to unfold the nucleotide-binding site to facilitate nucleotide exchange, and for the Ran proteins to achieve high affinity binding to karyopherins for secure transport through the nuclear pore.
A superimposition of all available complexes of GTPases revealed the quite surprising picture that the ‘flat’ side of the G domain formed by the C-terminal helix (α5) as long axis and a second axis from R128/R135 in helix α4 of H-Ras to the β-hairpin at residue 47 does not participate in any interactions with effectors, GDIs, GAPs or GEFs, except in case of Ran. Ran proteins use their C-terminus not for membrane attachment, but for shielding the binding site for its effectors in the GDP-bound form. Helix α4 is the least conserved part of small GTPases, it was found to be the major membrane interacting element (together with the C-terminal part of helix α5) in K-Ras (Prakash et al., 2015; 2016; Prakash and Gorfe, 2016), and it was speculated that helix α4 is an important determinant of specificity for cellular localization (Abankwa et al., 2010). As this helix is practically never involved in direct contacts with other proteins, it could achieve this function by influencing the interaction with the membrane.
Analysis of potential dimerization interfaces of small GTPases confirmed a possible interaction site exactly at the ‘flat’ surface of the G domain that is never (except in Ran proteins) covered by interacting proteins.
Most publications, original work as well as reviews, contain only comparisons to a limited set of related structures, so it might be fruitful in the future to look more often at the larger picture of the structures of this extended family of small GTP binding proteins. In this way, crystal structures can help to understand even the membrane interactions of these most versatile and ancient signaling proteins, in spite of the impossibility to crystallize them at a membrane.
The review summarizes the work that was achieved within the SFB 642. The German Science Foundation (DFG) is kindly acknowledged for continued financial funding. I would also like to thank all colleagues who helped with data collection, as well as the beamline staff of the synchrotrons ESRF, Grenoble, France, SLS, Villigen, Switzerland and PETRA, Hamburg, Germany.
Abankwa, D., Hanzal-Bayer, M., Ariotti, N., Plowman, S.J., Gorfe, A.A., Parton, R.G., McCammon, J.A., and Hancock, J.F. (2008). A novel switch region regulates H-ras membrane orientation and signal output. EMBO J. 27, 727–735.10.1038/emboj.2008.10Search in Google Scholar PubMed PubMed Central
Abankwa, D., Gorfe, A.A., Inder, K., and Hancock, J.F. (2010). Ras membrane orientation and nanodomain localization generate isoform diversity. Proc. Natl. Acad. Sci. USA 107, 1130–1135.10.1073/pnas.0903907107Search in Google Scholar PubMed PubMed Central
Buhrman, G., Wink, G., and Mattos, C. (2007). Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf. Struct. Fold. Design 15, 1618–1629.10.1016/j.str.2007.10.011Search in Google Scholar PubMed PubMed Central
Bürger, M., Zimmermann, T.J., Kondoh, Y., Stege, P., Watanabe, N., Osada, H., Waldmann, H., and Vetter, I.R. (2012). Crystal structure of the predicted phospholipase LYPLAL1 reveals unexpected functional plasticity despite close relationship to acyl protein thioesterases. J. Lipid Res. 53, 43–50.10.1194/jlr.M019851Search in Google Scholar PubMed PubMed Central
Burguete, A.S., Fenn, T.D., Brunger, A.T., and Pfeffer, S.R. (2008). Rab and Arl GTPase family members cooperate in the localization of the golgin GCC185. Cell 132, 286–298.10.1016/j.cell.2007.11.048Search in Google Scholar PubMed PubMed Central
Burkinshaw, B.J., Prehna, G., Worrall, L.J., and Strynadka, N.C.J. (2012). Structure of Salmonella effector protein SopB N-terminal domain in complex with host Rho GTPase Cdc42. J. Biol. Chem. 287, 13348–13355.10.1074/jbc.M111.331330Search in Google Scholar PubMed PubMed Central
Cheng, W., Yin, K., Lu, D., Li, B., Zhu, D., Chen, Y., Zhang, H., Xu, S., Chai, J., and Gu, L. (2012). Structural insights into a unique Legionella pneumophila effector LidA recognizing both GDP and GTP bound Rab1 in their active state. PLoS Pathog. 8, e1002528.10.1371/journal.ppat.1002528Search in Google Scholar PubMed PubMed Central
Collaborative Computational Project, Number 4 (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763.10.1107/S0907444994003112Search in Google Scholar PubMed
Cox, A.D., Der, C.J., and Philips, M.R. (2015). Targeting RAS membrane association: back to the future for anti-RAS drug discovery? Clin. Cancer Res. 21, 1819–1827.10.1158/1078-0432.CCR-14-3214Search in Google Scholar PubMed PubMed Central
Daumke, O., Weyand, M., Chakrabarti, P.P., Vetter, I.R., and Wittinghofer, A. (2004). The GTPase-activating protein Rap1GAP uses a catalytic asparagine. Nature 429, 197–201.10.1038/nature02505Search in Google Scholar PubMed
Dekker, F.J., Rocks, O., Vartak, N., Menninger, S., Hedberg, C., Balamurugan, R., Wetzel, S., Renner, S., Gerauer, M., Schölermann, B., et al. (2010). Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat. Chem. Biol. 6, 449–456.10.1038/nchembio.362Search in Google Scholar PubMed
Denayer, E., Parret, A., Chmara, M., Schubbert, S., Vogels, A., Devriendt, K., Frijns, J.P., Rybin, V., de Ravel, T.J., Shannon, K., et al. (2008). Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation. Hum. Mutat. 29, 232–239.10.1002/humu.20616Search in Google Scholar PubMed
Donaldson, J.G. and Jackson, C.L. (2011). ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat. Rev. Mol. Cell. Biol. 12, 362–375.10.1038/nrm3117Search in Google Scholar PubMed PubMed Central
Fansa, E.K., Kösling, S.K., Zent, E., Wittinghofer, A., and Ismail, S. (2016). PDE6δ-mediated sorting of INPP5E into the cilium is determined by cargo-carrier affinity. Nat. Commun. 7, 11366.10.1038/ncomms11366Search in Google Scholar PubMed PubMed Central
Fiegen, D., Haeusler, L.-C., Blumenstein, L., Herbrand, U., Dvorsky, R., Vetter, I.R., and Ahmadian, M.R. (2004). Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem. 279, 4743–4749.10.1074/jbc.M310281200Search in Google Scholar PubMed
Filchtinski, D., Sharabi, O., Rueppel, A., Vetter, I.R., Herrmann, C., and Shifman, J.M. (2010). What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf. J. Mol. Biol. 399, 422–435.10.1016/j.jmb.2010.03.046Search in Google Scholar PubMed
Forwood, J.K., Lonhienne, T.G., Marfori, M., Robin, G., Meng, W., Guncar, G., Liu, S.M., Stewart, M., Carroll, B.J., and Kobe, B. (2008). Kap95p binding induces the switch loops of RanGDP to adopt the GTP-bound conformation: implications for nuclear import complex assembly dynamics. J. Mol. Biol. 383, 772–782.10.1016/j.jmb.2008.07.090Search in Google Scholar PubMed
Franken, S.M., Scheidig, A.J., Krengel, U., Rensland, H., Lautwein, A., Geyer, M., Scheffzek, K., Goody, R.S., Kalbitzer, H.R., and Pai, E.F. (1993). Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. Biochemistry 32, 8411–8420.10.1021/bi00084a005Search in Google Scholar PubMed
Garavini, H., Riento, K., Phelan, J.P., McAlister, M.S.B., Ridley, A.J., and Keep, N.H. (2002). Crystal structure of the core domain of RhoE/Rnd3: a constitutively activated small G protein. Biochemistry 41, 6303–6310.10.1021/bi025651hSearch in Google Scholar PubMed
Gazdag, M.E., Streller, A., Haneburger, I., Hilbi, H., Vetter, I.R., Goody, R.S., and Itzen, A. (2013). Mechanism of Rab1b deactivation by the Legionella pneumophila GAP LepB. EMBO Rep 14, 199–205.10.1038/embor.2012.211Search in Google Scholar PubMed PubMed Central
Gillingham, A.K. and Munro, S. (2007). The small G proteins of the Arf family and their regulators. Annu. Rev. Cell Dev. Biol. 23, 579–611.10.1146/annurev.cellbio.23.090506.123209Search in Google Scholar PubMed
Gingras, A.R., Puzon-McLaughlin, W., and Ginsberg, M.H. (2013). The Structure of the ternary complex of Krev Interaction Trapped 1 (KRIT1) bound to both the Rap1 GTPase and the Heart of Glass (HEG1) cytoplasmic tail. J. Biol. Chem. 288, 23639–23649.10.1074/jbc.M113.462911Search in Google Scholar PubMed PubMed Central
Gorfe, A.A., Hanzal-Bayer, M., Abankwa, D., Hancock, J.F., and McCammon, J.A. (2007). Structure and dynamics of the full-length lipid-modified H-ras protein in a 1,2-dimyristoylglycero-3-phosphocholine bilayer. J. Med. Chem. 50, 674–684.10.1021/jm061053fSearch in Google Scholar PubMed
Görmer, K., Bürger, M., Kruijtzer, J.A.W., Vetter, I., Vartak, N., Brunsveld, L., Bastiaens, P., Liskamp, R.M.J., Triola, G., and Waldmann, H. (2012). Chemical-biological exploration of the limits of the Ras de- and repalmitoylating machinery. ChemBioChem 13, 1017–1023.10.1002/cbic.201200078Search in Google Scholar PubMed
Grizot, S., Fauré, J., Fieschi, F., Vignais, P.V., Dagher, M.C., and Pebay-Peyroula, E. (2001). Crystal structure of the Rac1-RhoGDI complex involved in NADPH oxidase activation. Biochemistry 40, 10007–10013.10.1021/bi010288kSearch in Google Scholar PubMed
Güldenhaupt, J., Rudack, T., Bachler, P., Mann, D., Triola, G., Waldmann, H., Kötting, C., and Gerwert, K. (2012). N-Ras forms dimers at POPC membranes. Biophys. J. 103, 1585–1593.10.1016/j.bpj.2012.08.043Search in Google Scholar PubMed PubMed Central
Güttler, T., Madl, T., Neumann, P., Deichsel, D., Corsini, L., Monecke, T., Ficner, R., Sattler, M., and Görlich, D. (2010). NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1. Nat. Struct. Mol. Biol. 17, 1367–1376.10.1038/nsmb.1931Search in Google Scholar
Hanawa-Suetsugu, K., Kukimoto-Niino, M., Mishima-Tsumagari, C., Akasaka, R., Ohsawa, N., Sekine, S., Ito, T., Tochio, N., Koshiba, S., Kigawa, T., et al. (2012). Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms. Proc. Natl. Acad. Sci. USA 109, 3305–3310.10.1073/pnas.1113512109Search in Google Scholar
Hanzal-Bayer, M., Renault, L., Roversi, P., Wittinghofer, A., and Hillig, R.C. (2002). The complex of Arl2-GTP and PDE delta: from structure to function. EMBO J 21, 2095–2106.10.1093/emboj/21.9.2095Search in Google Scholar
Harada, Y., Tanaka, Y., Terasawa, M., Pieczyk, M., Habiro, K., Katakai, T., Hanawa-Suetsugu, K., Kukimoto-Niino, M., Nishizaki, T., Shirouzu, M., et al. (2012). DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 119, 4451–4461.10.1182/blood-2012-01-407098Search in Google Scholar
Hoffman, G.R., Nassar, N., and Cerione, R.A. (2000). Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100, 345–356.10.1016/S0092-8674(00)80670-4Search in Google Scholar
Holbourn, K.P., Sutton, J.M., Evans, H.R., Shone, C.C., and Acharya, K.R. (2005). Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase. Proc. Natl. Acad. Sci. USA 102, 5357–5362.10.1073/pnas.0501525102Search in Google Scholar PubMed PubMed Central
Huang, M., Weissman, J.T., Beraud-Dufour, S., Luan, P., Wang, C., Chen, W., Aridor, M., Wilson, I.A., and Balch, W.E. (2001). Crystal structure of Sar1-GDP at 1.7 Å resolution and the role of the NH2 terminus in ER export. J. Cell Biol. 155, 937–948.10.1083/jcb.200106039Search in Google Scholar PubMed PubMed Central
Ignatev, A., Kravchenko, S., Rak, A., Goody, R.S., and Pylypenko, O. (2008). A structural model of the GDP dissociation inhibitor Rab membrane extraction mechanism. J. Biol. Chem. 283, 18377–18384.10.1074/jbc.M709718200Search in Google Scholar PubMed
Inouye, K., Mizutani, S., Koide, H., and Kaziro, Y. (2000). Formation of the Ras dimer is essential for Raf-1 activation. J. Biol. Chem. 275, 3737–3740.10.1074/jbc.275.6.3737Search in Google Scholar PubMed
Isabet, T., Montagnac, G., Regazzoni, K., Raynal, B., Khadali, El, F., England, P., Franco, M., Chavrier, P., Houdusse, A., and Ménétrey, J. (2009). The structural basis of Arf effector specificity: the crystal structure of ARF6 in a complex with JIP4. EMBO J 28, 2835–2845.10.1038/emboj.2009.209Search in Google Scholar PubMed PubMed Central
Ismail, S.A., Vetter, I.R., Sot, B., and Wittinghofer, A. (2010). The structure of an Arf-ArfGAP complex reveals a Ca2+ regulatory mechanism. Cell 141, 812–821.10.1016/j.cell.2010.03.051Search in Google Scholar PubMed
Ismail, S.A., Chen, Y.-X., Rusinova, A., Chandra, A., Bierbaum, M., Gremer, L., Triola, G., Waldmann, H., Bastiaens, P.I.H., and Wittinghofer, A. (2011). Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo. Nat. Chem. Biol. 7, 942–949.10.1038/nchembio.686Search in Google Scholar PubMed
Ismail, S.A., Chen, Y.-X., Miertzschke, M., Vetter, I.R., Koerner, C., and Wittinghofer, A. (2012). Structural basis for Arl3-specific release of myristoylated ciliary cargo from UNC119. EMBO J 31, 4085–4094.10.1038/emboj.2012.257Search in Google Scholar PubMed PubMed Central
Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., and Nussinov, R. (2016). Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers. Biochem. J. 473, 1719–1732.10.1042/BCJ20160031Search in Google Scholar PubMed PubMed Central
Kapoor, S., Triola, G., Vetter, I.R., Erlkamp, M., Waldmann, H., and Winter, R. (2012). Revealing conformational substates of lipidated N-Ras protein by pressure modulation. Proc. Natl. Acad. Sci. USA 109, 460–465.10.1073/pnas.1110553109Search in Google Scholar PubMed PubMed Central
Kemp, L.E., Rusch, M., Adibekian, A., Bullen, H.E., Graindorge, A., Freymond, C., Rottmann, M., Braun-Breton, C., Baumeister, S., Porfetye, A.T., et al. (2013). Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii. J. Biol. Chem. 288, 27002–27018.10.1074/jbc.M113.460709Search in Google Scholar PubMed PubMed Central
Kuhlmann, N., Wroblowski, S., Knyphausen, P., de Boor, S., Brenig, J., Zienert, AY., Meyer-Teschendorf, K., Praefcke, GJ., Nolte, H., Krüger, M., et al. (2016). Structural and mechanistic insights into the regulation of the fundamental rho regulator RhoGDIα by lysine acetylation. EMBO J 291, 2064–2076.10.1074/jbc.M115.707091Search in Google Scholar PubMed PubMed Central
Kühn, S., Erdmann, C., Kage, F., Block, J., Schwenkmezger, L., Steffen, A., Rottner, K., and Geyer, M. (2015). The structure of FMNL2-Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation. Nat. Commun. 6, 7088.10.1038/ncomms8088Search in Google Scholar PubMed PubMed Central
Kukimoto-Niino, M., Sakamoto, A., Kanno, E., Hanawa-Suetsugu, K., Terada, T., Shirouzu, M., Fukuda, M., and Yokoyama, S. (2008). Structural basis for the exclusive specificity of Slac2-a/melanophilin for the Rab27 GTPases. Struct. Fold. Design 16, 1478–1490.10.1016/j.str.2008.07.014Search in Google Scholar PubMed
Kulkarni, K., Yang, J., Zhang, Z., and Barford, D. (2011). Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors. J. Biol. Chem. 286, 25341–25351.10.1074/jbc.M111.236455Search in Google Scholar PubMed PubMed Central
Leipe, D.D., Wolf, Y.I., Koonin, E.V., and Aravind, L. (2002). Classification and evolution of P-loop GTPases and related ATPases. J. Mol. Biol. 317, 41–72.10.1006/jmbi.2001.5378Search in Google Scholar PubMed
Li, X., Zhang, R., Draheim, K.M., Liu, W., Calderwood, D.A., and Boggon, T.J. (2012). Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1). J. Biol. Chem. 287, 22317–22327.10.1074/jbc.M112.361295Search in Google Scholar PubMed PubMed Central
Lin, D.T.S. and Conibear, E. (2015). ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. eLife 4, e11306.10.7554/eLife.11306.017Search in Google Scholar
Ma, B.-G., Chen, L., Ji, H.-F., Chen, Z.-H., Yang, F.-R., Wang, L., Qu, G., Jiang, Y.-Y., Ji, C., and Zhang, H.-Y. (2008). Characters of very ancient proteins. Biochem. Biophys. Res. Commun. 366, 607–611.10.1016/j.bbrc.2007.12.014Search in Google Scholar PubMed
Maurer, T., Garrenton, L.S., Oh, A., Pitts, K., Anderson, D.J., Skelton, N.J., Fauber, B.P., Pan, B., Malek, S., Stokoe, D., et al. (2012). Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proc. Natl. Acad. Sci. USA 109, 5299–5304.10.1073/pnas.1116510109Search in Google Scholar PubMed PubMed Central
Miertzschke, M., Koerner, C., Vetter, I.R., Keilberg, D., Hot, E., Leonardy, S., gaard-Andersen, L.S.O., and Wittinghofer, A. (2011). Structural analysis of the Ras-like G protein MglA and its cognate GAP MglB and implications for bacterial polarity. EMBO J. 30, 4185–4197.10.1038/emboj.2011.291Search in Google Scholar PubMed PubMed Central
Milburn, M.V., Tong, L., deVos, A.M., Brünger, A., Yamaizumi, Z., Nishimura, S., and Kim, S.H. (1990). Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science 247, 939–945.10.1126/science.2406906Search in Google Scholar PubMed
Mishra, A.K., Del Campo, C.M., Collins, R.E., Roy, C.R., and Lambright, D.G. (2013). The Legionella pneumophila GTPase activating protein LepB accelerates Rab1 deactivation by a non-canonical hydrolytic mechanism. J. Biol. Chem. 288, 24000–24011.10.1074/jbc.M113.470625Search in Google Scholar PubMed PubMed Central
Muratcioglu, S., Chavan, T.S., Freed, B.C., Jang, H., Khavrutskii, L., Freed, R.N., Dyba, M.A., Stefanisko, K., Tarasov, S.G., Gursoy, A., et al. (2015). GTP-Dependent K-Ras Dimerization. Structure 23, 1325–1335.10.1016/j.str.2015.04.019Search in Google Scholar PubMed PubMed Central
Nan, X., Tamgüney, T.M., Collisson, E.A., Lin, L.-J., Pitt, C., Galeas, J., Lewis, S., Gray, J.W., McCormick, F., and Chu, S. (2015). Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proc. Natl. Acad. Sci. USA 112, 7996–8001.10.1073/pnas.1509123112Search in Google Scholar PubMed PubMed Central
Ostrem, J.M., Peters, U., Sos, M.L., Wells, J.A., and Shokat, K.M. (2013). K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548–551.10.1038/nature12796Search in Google Scholar PubMed PubMed Central
Pasqualato, S., Renault, L., and Cherfils, J. (2002). Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for “front-back” communication. EMBO Rep. 3, 1035–1041.10.1093/embo-reports/kvf221Search in Google Scholar PubMed PubMed Central
Pautsch, A., Vogelsgesang, M., Tränkle, J., Herrmann, C., and Aktories, K. (2005). Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme. EMBO J. 24, 3670–3680.10.1038/sj.emboj.7600813Search in Google Scholar PubMed PubMed Central
Prakash, P., Hancock, J.F., and Gorfe, A.A. (2015). Binding hotspots on K-ras: consensus ligand binding sites and other reactive regions from probe-based molecular dynamics analysis. Proteins 83, 898–909.10.1002/prot.24786Search in Google Scholar PubMed PubMed Central
Prakash, P., Zhou, Y., Liang, H., Hancock, J.F., and Gorfe, A.A. (2016). Oncogenic K-Ras binds to an anionic membrane in two distinct orientations: a molecular dynamics analysis. Biophys. J. 110, 1125–1138.10.1016/j.bpj.2016.01.019Search in Google Scholar PubMed PubMed Central
Premkumar, L., Bobkov, A.A., Patel, M., Jaroszewski, L., Bankston, L.A., Stec, B., Vuori, K., Côté, J.-F., and Liddington, R.C. (2010). Structural basis of membrane targeting by the Dock180 family of Rho family guanine exchange factors (Rho-GEFs). J. Biol. Chem. 285, 13211–13222.10.1074/jbc.M110.102517Search in Google Scholar PubMed PubMed Central
Rak, A., Pylypenko, O., Durek, T., Watzke, A., Kushnir, S., Brunsveld, L., Waldmann, H., Goody, R.S., and Alexandrov, K. (2003). Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase. Science 302, 646–650.10.1126/science.1087761Search in Google Scholar PubMed
Rak, A., Pylypenko, O., Niculae, A., Pyatkov, K., Goody, R.S., and Alexandrov, K. (2004). Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell 117, 749–760.10.1016/j.cell.2004.05.017Search in Google Scholar PubMed
Recacha, R., Boulet, A., Jollivet, F., Monier, S., Houdusse, A., Goud, B., and Khan, A.R. (2009). Structural basis for recruitment of Rab6-interacting protein 1 to Golgi via a RUN domain. Struct. Fold. Design 17, 21–30.10.1016/j.str.2008.10.014Search in Google Scholar PubMed
Remans, K., Bürger, M., Vetter, I.R., and Wittinghofer, A. (2014). C2 domains as protein-protein interaction modules in the ciliary transition zone. Cell Rep 8, 1–9.10.1016/j.celrep.2014.05.049Search in Google Scholar PubMed
Rosnizeck, I.C., Graf, T., Spoerner, M., Tränkle, J., Filchtinski, D., Herrmann, C., Gremer, L., Vetter, I.R., Wittinghofer, A., König, B., et al. (2010). Stabilisierung eines niederaffinen Zustands für Effektoren im menschlichen Ras-Protein durch Cyclenkomplexe. Angew. Chem. 122, 3918–3922.10.1002/ange.200907002Search in Google Scholar
Rudack, T., Jenrich, S., Brucker, S., Vetter, I.R., Gerwert, K., and Kötting, C. (2015). Catalysis of GTP hydrolysis by small GTPases at atomic detail by integration of X-ray crystallography, experimental, and theoretical IR spectroscopy. J. Biol. Chem. 290, 24079–24090.10.1074/jbc.M115.648071Search in Google Scholar PubMed PubMed Central
Rusch, M., Zimmermann, T.J., Bürger, M., Dekker, F.J., Görmer, K., Triola, G., Brockmeyer, A., Janning, P., Böttcher, T., Sieber, S.A., et al. (2011). Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the ras-signaling modulators palmostatin B and M. Angew. Chem. Int. Ed. 50, 9838–9842.10.1002/anie.201102967Search in Google Scholar PubMed
Sarić, M., Zhao, X., Körner, C., Nowak, C., Kuhlmann, J., and Vetter, I.R. (2007). Structural and biochemical characterization of the Importin-β.Ran.GTP.RanBD1 complex. FEBS Lett. 581, 1369–1376.10.1016/j.febslet.2007.02.067Search in Google Scholar PubMed
Sayyed-Ahmad, A., Cho, K.-J., Hancock, J.F., and Gorfe, A.A. (2016). Computational equilibrium thermodynamic and kinetic analysis of K-Ras dimerization through an effector binding surface suggests limited functional role. J. Phys. Chem. B 120, 8547–8556.10.1021/acs.jpcb.6b02403Search in Google Scholar PubMed PubMed Central
Scapin, S.M.N., Carneiro, F.R.G., Alves, A.C., Medrano, F.J., Guimarães, B.G., and Zanchin, N.I.T. (2006). The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform. J. Struct. Biol.154, 260–268.10.1016/j.jsb.2006.01.007Search in Google Scholar
Scheffzek, K., Ahmadian, M.R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., and Wittinghofer, A. (1997). The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277, 333–338.10.1126/science.277.5324.333Search in Google Scholar
Scheidig, A.J., Burmester, C., and Goody, R.S. (1999). The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins. Struct. Fold. Design 7, 1311–1324.10.1016/S0969-2126(00)80021-0Search in Google Scholar
Schrader, N., Koerner, C., Koessmeier, K., Bangert, J.-A., Wittinghofer, A., Stoll, R., and Vetter, I.R. (2008). The crystal structure of the Ran-Nup153ZnF2 complex: a general Ran docking site at the nuclear pore complex. Struct. Fold. Design 16, 1116–1125.10.1016/j.str.2008.03.014Search in Google Scholar PubMed
Scrima, A., Thomas, C., Deaconescu, D., and Wittinghofer, A. (2008). The Rap-RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues. EMBO J 27, 1145–1153.10.1038/emboj.2008.30Search in Google Scholar PubMed PubMed Central
Seewald, M.J., Kraemer, A., Farkasovsky, M., Körner, C., Wittinghofer, A., and Vetter, I.R. (2003). Biochemical characterization of the Ran-RanBP1-RanGAP system: are RanBP proteins and the acidic tail of RanGAP required for the Ran-RanGAP GTPase reaction? Mol. Cell. Biol. 23, 8124.10.1128/MCB.23.22.8124-8136.2003Search in Google Scholar PubMed PubMed Central
Shima, F., Ijiri, Y., Muraoka, S., Liao, J., Ye, M., Araki, M., Matsumoto, K., Yamamoto, N., Sugimoto, T., Yoshikawa, Y., et al. (2010). Structural basis for conformational dynamics of GTP-bound Ras protein. J. Biol. Chem. 285, 22696–22705.10.1074/jbc.M110.125161Search in Google Scholar PubMed PubMed Central
Spoerner, M., Herrmann, C., Vetter, I.R., Kalbitzer, H.R., and Wittinghofer, A. (2001). Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proc. Natl. Acad. Sci. USA 98, 4944–4949.10.1073/pnas.081441398Search in Google Scholar PubMed PubMed Central
Sun, Q., Burke, J.P., Phan, J., Burns, M.C., Olejniczak, E.T., Waterson, A.G., Lee, T., Rossanese, O.W., and Fesik, S.W. (2012). Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation. Angew. Chem. Int. Ed. 51, 6140–6143.10.1002/anie.201201358Search in Google Scholar PubMed PubMed Central
Šolman, M., Ligabue, A., Blaževitš, O., Jaiswal, A., Zhou, Y., Liang, H., Lectez, B., Kopra, K., Guzmán, C., Härmä, H., et al. (2015). Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation. eLife 4, e08905.10.7554/eLife.08905.020Search in Google Scholar
Tarricone, C., Xiao, B., Justin, N., Walker, P.A., Rittinger, K., Gamblin, S.J., and Smerdon, S.J. (2001). The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways. Nature 411, 215–219.10.1038/35075620Search in Google Scholar
Thomas, D.M., Ferguson, G.D., Herschman, H.R., and Elferink, L.A. (1999). Functional and biochemical analysis of the C2 domains of synaptotagmin IV. Mol. Biol. Cell 10, 2285–2295.10.1091/mbc.10.7.2285Search in Google Scholar
Tnimov, Z., Guo, Z., Gambin, Y., Nguyen, U.T., Wu, Y.W., Abankwa, D., Stigter, A., Collins, B.M., Waldmann, H., Goody, R.S., et al. (2012). Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI. J. Biol. Chem. 287, 26549–26562.10.1074/jbc.M112.371294Search in Google Scholar
Tsai, F.D., Lopes, M.S., Zhou, M., Court, H., Ponce, O., Fiordalisi, J.J., Gierut, J.J., Cox, A.D., Haigis, K.M., and Philips, M.R. (2015). K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif. Proc. Natl. Acad. Sci. USA 112, 779–784.10.1073/pnas.1412811112Search in Google Scholar
Vetter, I.R. (2014). The structure of the G domain of the ras superfamily. In: Ras Superfamily Small G Proteins: Biology and Mechanisms Part I, A. Wittinghofer, ed. pp. 25–50.Search in Google Scholar
Vetter, I.R. and Wittinghofer, A. (1999). Nucleoside triphosphate-binding proteins: different scaffolds to achieve phosphoryl transfer. Q. Rev. Biophys. 32, 1–56.10.1017/S0033583599003480Search in Google Scholar
Vetter, I.R., Arndt, A., Kutay, U., Gorlich, D., and Wittinghofer, A. (1999a). Structural view of the Ran-importin β interaction at 2.3 Å resolution. Cell 97, 635–646.10.1016/S0092-8674(00)80774-6Search in Google Scholar
Vetter, I.R., Nowak, C., Nishimoto, T., Kuhlmann, J., and Wittinghofer, A. (1999b). Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport. Nature 398, 39–46.10.1038/17969Search in Google Scholar PubMed
Vidal, C.J. (2010). Post-translational Modifications in Health and Disease. (New York: Springer Science & Business Media).Search in Google Scholar
Villa Braslavsky, C.I., Nowak, C., Görlich, D., Wittinghofer, A., and Kuhlmann, J. (2000). Different structural and kinetic requirements for the interaction of Ran with the Ran-binding domains from RanBP2 and importin-β. Biochemistry 39, 11629–11639.10.1021/bi001010fSearch in Google Scholar PubMed
Vujic, I., Sanlorenzo, M., Esteve-Puig, R., Vujic, M., Kwong, A., Tsumura, A., Murphy, R., Moy, A., Posch, C., Monshi, B., et al. (2016). Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Oncotarget 7, 7297–7306.10.18632/oncotarget.6907Search in Google Scholar PubMed PubMed Central
Wang, Y., Pascoe, H.G., Brautigam, C.A., He, H., and Zhang, X. (2013). Structural basis for activation and non-canonical catalysis of the Rap GTPase activating protein domain of plexin. eLife 2, e01279.10.7554/eLife.01279.020Search in Google Scholar
Wätzlich, D., Vetter, I., Gotthardt, K., Miertzschke, M., Chen, Y.-X., Wittinghofer, A., and Ismail, S. (2013). The interplay between RPGR, PDEδ and Arl2/3 regulate the ciliary targeting of farnesylated cargo. EMBO Rep. 14, 465–472.10.1038/embor.2013.37Search in Google Scholar PubMed PubMed Central
Wittinghofer, A. and Vetter, I.R. (2011). Structure-function relationships of the G domain, a canonical switch motif. Annu. Rev. Biochem. 80, 943–971.10.1146/annurev-biochem-062708-134043Search in Google Scholar PubMed
Xiao, J., Worby, C.A., Mattoo, S., Sankaran, B., and Dixon, J.E. (2010). Structural basis of Fic-mediated adenylylation. Nat Struct Mol Biol 17, 1004–1010.10.1038/nsmb.1867Search in Google Scholar PubMed PubMed Central
Yang, J., Zhang, Z., Roe, S.M., Marshall, C.J., and Barford, D. (2009). Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor. Science 325, 1398–1402.10.1126/science.1174468Search in Google Scholar PubMed
Yu, Q., Hu, L., Yao, Q., Zhu, Y., Dong, N., Wang, D.-C., and Shao, F. (2013). Structural analyses of Legionella LepB reveal a new GAP fold that catalytically mimics eukaryotic RasGAP. Cell Res. 23, 775–787.10.1038/cr.2013.54Search in Google Scholar PubMed PubMed Central
Zahn, R., Osmanović, D., Ehret, S., Araya Callis, C., Frey, S., Stewart, M., You, C., Görlich, D., Hoogenboom, B.W., and Richter, R.P. (2016). A physical model describing the interaction of nuclear transport receptors with FG nucleoporin domain assemblies. eLife 5, 1–21.10.7554/eLife.14119.025Search in Google Scholar
Zawistowski, J.S., Stalheim, L., Uhlik, M.T., Abell, A.N., Ancrile, B.B., Johnson, G.L., and Marchuk, D.A. (2005). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14, 2521–2531.10.1093/hmg/ddi256Search in Google Scholar PubMed
Zimmermann, T.J., Bürger, M., Tashiro, E., Kondoh, Y., Martinez, N.E., Görmer, K., Rosin-Steiner, S., Shimizu, T., Ozaki, S., Mikoshiba, K., et al. (2013). Boron-based inhibitors of acyl protein thioesterases 1 and 2. ChemBioChem 14, 115–122.10.1002/cbic.201200571Search in Google Scholar PubMed
Zong, H., Kaibuchi, K., and Quilliam, L.A. (2001). The insert region of RhoA is essential for Rho kinase activation and cellular transformation. Mol. Cell. Biol.21, 5287–5298.10.1128/MCB.21.16.5287-5298.2001Search in Google Scholar PubMed PubMed Central
©2017, Ingrid R. Vetter, published by De Gruyter.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.